UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Heterologous AD5-nCOV plus CoronaVac versus homologous CoronaVac vaccination: a randomized phase 4 trial

Nature medicine, 2022-02, Vol.28 (2), p.401-409

2022

Volltextzugriff (PDF)

Safety and immunogenicity of the SARS-CoV-2 BNT162b1 mRNA vaccine in younger and older Chinese adults: a randomized, placebo-controlled, double-blind phase 1 study

Nature medicine, 2021-06, Vol.27 (6), p.1062-1070

2021

Volltextzugriff (PDF)

Immunological surrogate endpoints of COVID-2019 vaccines: the evidence we have versus the evidence we need

Signal transduction and targeted therapy, 2021-02, Vol.6 (1), p.48-48, Article 48

2021

Volltextzugriff (PDF)

Six-month follow-up of a booster dose of CoronaVac in two single-centre phase 2 clinical trials

Nature communications, 2022-06, Vol.13 (1), p.3100-3100, Article 3100

2022

Volltextzugriff (PDF)

Safety and immunogenicity of heterologous boost immunization with an adenovirus type-5-vectored and protein-subunit-based COVID-19 vaccine (Convidecia/ZF2001): A randomized, observer-blinded, placebo-controlled trial

PLoS medicine, 2022-05, Vol.19 (5), p.e1003953-e1003953

2022

Volltextzugriff (PDF)

Changes of the relationship between spring sand dust frequency and large-scale atmospheric circulation

Atmospheric research, 2019-09, Vol.226, p.102-109

2019

Volltextzugriff (PDF)

Safety and immunogenicity of a modified Omicron-adapted inactivated vaccine in healthy adults: a randomized, double-blind, active-controlled Phase III clinical trial

Frontiers in immunology, 2023-09, Vol.14, p.1241153-1241153

2023

Volltextzugriff (PDF)

A head-to-head comparison of humoral and cellular immune responses of five COVID-19 vaccines in adults in China

Frontiers in immunology, 2024-08, Vol.15, p.1455730

2024

Volltextzugriff (PDF)

Safety and immunogenicity of the SARS-CoV-2 LYB001 RBD-based VLP vaccine (CHO cell) phase 1 in Chinese adults: a randomized, double-blind, positive-parallel-controlled study

Expert review of vaccines, 2024, Vol.23 (1), p.498-509

2024

Volltextzugriff (PDF)

Evaluation of human antibodies from vaccinated volunteers for protection against Yersinia pestis infection

Microbiology spectrum, 2024-10, Vol.12 (10), p.e0105424

2024

Volltextzugriff (PDF)

Antibody persistence and safety after heterologous boosting with orally aerosolised Ad5-nCoV in individuals primed with two-dose CoronaVac previously: 12-month analyses of a randomized controlled trial

Emerging microbes & infections, 2023-12, Vol.12 (1), p.2155251

2023

Volltextzugriff (PDF)

Lot-to-lot consistency, immunogenicity, and safety of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults: A randomized, double-blind, phase IV trial

Human vaccines & immunotherapeutics, 2022-11, Vol.18 (6), p.2135929-2135929

2022

Volltextzugriff (PDF)

Relative effectiveness of a heterologous booster dose with adenovirus type 5 vectored COVID-19 vaccine versus three doses of inactivated COVID-19 vaccine in adults during a nationwide outbreak of omicron predominance, in China: a retrospective, individually matched cohort-control study

Emerging microbes & infections, 2024-12, Vol.13 (1), p.2332660-2332660

2024

Volltextzugriff (PDF)

Immunogenicity and Safety of One versus Two Doses of Quadrivalent Inactivated Influenza Vaccine (IIV4) in Vaccine-Unprimed Children and One Dose of IIV4 in Vaccine-Primed Children Aged 3–8 Years

Vaccines (Basel), 2023-10, Vol.11 (10), p.1586

2023

Volltextzugriff (PDF)

A randomized, open-label, phase 3 study evaluating safety and immunogenicity of 13-valent pneumococcal conjugate vaccine in Chinese infants and children under 6 years of age

Human vaccines & immunotherapeutics, 2023-08, Vol.19 (2), p.2235926-2235926

2023

Volltextzugriff (PDF)

In-situ synthesis of hierarchically porous and polycrystalline carbon nanowires with excellent microwave absorption performance

Carbon (New York), 2016-10, Vol.107, p.36-45

2016

Volltextzugriff (PDF)

Immunogenicity and safety of BNT162b2 mRNA vaccine in Chinese adults: A phase 2 randomised clinical trial

The Lancet regional health. Western Pacific, 2022-12, Vol.29, p.100586-100586, Article 100586

2022

Volltextzugriff (PDF)

A randomized, double‐blind, placebo‐controlled phase 1 and phase 2 clinical trial to evaluate efficacy and safety of a SARS‐CoV‐2 vaccine SCoK in adults

Clinical and translational medicine, 2022-09, Vol.12 (9), p.n/a

2022

Volltextzugriff (PDF)

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

The Lancet infectious diseases, 2021-02, Vol.21 (2), p.181-192

2021

Volltextzugriff (PDF)

Electrospinning of graphite/SiC hybrid nanowires with tunable dielectric and microwave absorption characteristics

Composites. Part A, Applied science and manufacturing, 2018-01, Vol.104, p.68-80

2018

Volltextzugriff (PDF)

Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials

The Lancet infectious diseases, 2022-04, Vol.22 (4), p.483-495

2022

Volltextzugriff (PDF)

Microwave-absorption properties of SiOC ceramics derived from novel hyperbranched ferrocene-containing polysiloxane

Journal of the European Ceramic Society, 2017-05, Vol.37 (5), p.2021-2030

2017

Volltextzugriff (PDF)

Safety and Immunogenicity of a Recombinant Adenovirus Type-5–Vectored Coronavirus Disease 2019 (COVID-19) Vaccine With a Homologous Prime-Boost Regimen in Healthy Participants Aged ≥6 Years: A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Trial

Clinical infectious diseases, 2022-08, Vol.75 (1), p.e783-e791

2022

Volltextzugriff (PDF)

Assessment of site suitability for centralized photovoltaic power stations in Northwest China's six provinces

Journal of environmental management, 2024-08, Vol.366, p.121820, Article 121820

2024

Volltextzugriff (PDF)

Safety and immunogenicity of two subunit influenza vaccines in healthy children, adults and the elderly: A randomized controlled trial in China

Vaccine, 2008-08, Vol.26 (35), p.4579-4584

2008

Volltextzugriff (PDF)

1 – 25 von 306

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(249)
Mit Volltextzugriff
(261)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(215)
Life Sciences & Biomedicine
(95)
Technology
(78)
Physical Sciences
(76)
Humans
(69)
Materials Science
(49)
Materials Science, Multidisciplinary
(42)
Male
(41)
Physics
(40)
Science & Technology - Other Topics
(40)
Chemistry
(38)
Female
(37)
Adult
(29)
Nanoscience & Nanotechnology
(27)
Physics, Applied
(27)
Engineering
(24)
Chemistry, Multidisciplinary
(22)
Adolescent
(20)
Chemistry, Physical
(20)
Child
(18)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Heterologous AD5-nCOV plus CoronaVac versus homologous CoronaVac vaccination: a randomized phase 4 trial

Safety and immunogenicity of the SARS-CoV-2 BNT162b1 mRNA vaccine in younger and older Chinese adults: a randomized, placebo-controlled, double-blind phase 1 study

Immunological surrogate endpoints of COVID-2019 vaccines: the evidence we have versus the evidence we need

Six-month follow-up of a booster dose of CoronaVac in two single-centre phase 2 clinical trials

Safety and immunogenicity of heterologous boost immunization with an adenovirus type-5-vectored and protein-subunit-based COVID-19 vaccine (Convidecia/ZF2001): A randomized, observer-blinded, placebo-controlled trial

Changes of the relationship between spring sand dust frequency and large-scale atmospheric circulation

Safety and immunogenicity of a modified Omicron-adapted inactivated vaccine in healthy adults: a randomized, double-blind, active-controlled Phase III clinical trial

A head-to-head comparison of humoral and cellular immune responses of five COVID-19 vaccines in adults in China

Safety and immunogenicity of the SARS-CoV-2 LYB001 RBD-based VLP vaccine (CHO cell) phase 1 in Chinese adults: a randomized, double-blind, positive-parallel-controlled study

Evaluation of human antibodies from vaccinated volunteers for protection against Yersinia pestis infection

Antibody persistence and safety after heterologous boosting with orally aerosolised Ad5-nCoV in individuals primed with two-dose CoronaVac previously: 12-month analyses of a randomized controlled trial

Lot-to-lot consistency, immunogenicity, and safety of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults: A randomized, double-blind, phase IV trial

Relative effectiveness of a heterologous booster dose with adenovirus type 5 vectored COVID-19 vaccine versus three doses of inactivated COVID-19 vaccine in adults during a nationwide outbreak of omicron predominance, in China: a retrospective, individually matched cohort-control study

Immunogenicity and Safety of One versus Two Doses of Quadrivalent Inactivated Influenza Vaccine (IIV4) in Vaccine-Unprimed Children and One Dose of IIV4 in Vaccine-Primed Children Aged 3–8 Years

A randomized, open-label, phase 3 study evaluating safety and immunogenicity of 13-valent pneumococcal conjugate vaccine in Chinese infants and children under 6 years of age

In-situ synthesis of hierarchically porous and polycrystalline carbon nanowires with excellent microwave absorption performance

Immunogenicity and safety of BNT162b2 mRNA vaccine in Chinese adults: A phase 2 randomised clinical trial

A randomized, double‐blind, placebo‐controlled phase 1 and phase 2 clinical trial to evaluate efficacy and safety of a SARS‐CoV‐2 vaccine SCoK in adults

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

Electrospinning of graphite/SiC hybrid nanowires with tunable dielectric and microwave absorption characteristics

Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials

Microwave-absorption properties of SiOC ceramics derived from novel hyperbranched ferrocene-containing polysiloxane

Safety and Immunogenicity of a Recombinant Adenovirus Type-5–Vectored Coronavirus Disease 2019 (COVID-19) Vaccine With a Homologous Prime-Boost Regimen in Healthy Participants Aged ≥6 Years: A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Trial

Assessment of site suitability for centralized photovoltaic power stations in Northwest China's six provinces

Safety and immunogenicity of two subunit influenza vaccines in healthy children, adults and the elderly: A randomized controlled trial in China

Suchergebnisse filtern